Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04537871

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

Cardiovascular Reserve Evaluation in Survivors of Transplantation (CREST)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
350 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates how well the heart, lungs, and muscles are working individually, and how these systems are working together in transplant survivors. Information collected in this study may help doctors to understand why hematopoietic stem cell transplant survivors are at higher risk for developing cardiovascular disease.

Detailed description

PRIMARY OBJECTIVES: I. Evaluate cardiovascular reserve capacity, as measured by peak oxygen consumption (VO2peak), in hematopoietic cell transplantation (HCT) survivors. II. Define the determinants of VO2peak impairment in HCT survivors. OUTLINE: Patients undergo echocardiogram to assess cardiac function and mechanics, cardiopulmonary exercise test, pulmonary function test, musculoskeletal ultrasound, bioelectrical impedance analysis to measure total lean body mass and percent body fat), physical function tests, and collection of blood samples within 45 days from the start of conditioning therapy, and at 6 months, 1 year, and 2 years post-transplant.

Conditions

Interventions

TypeNameDescription
PROCEDUREBioelectric Impedance AnalysisUndergo bioelectric impedance analysis
PROCEDUREBiospecimen CollectionUndergo collection of blood samples
PROCEDURECardiopulmonary Exercise TestingUndergo cardiopulmonary exercise test
PROCEDUREEchocardiographyUndergo echocardiogram
PROCEDUREPhysical Performance TestingUndergo physical function tests
PROCEDUREPulmonary Function TestUndergo pulmonary function test
OTHERQuestionnaire AdministrationAncillary studies
PROCEDUREUltrasoundUndergo musculoskeletal ultrasound

Timeline

Start date
2020-11-18
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2020-09-03
Last updated
2025-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04537871. Inclusion in this directory is not an endorsement.